etrolizumab (RG7413) - Roche
Etrolizumab: NME submission in US for ulcerative colitis in 2020 (Roche) - Jan 30, 2020 - FY 2019 Results: Regulatory submission in EU for ulcerative colitis in 2020 
BLA • European regulatory
https://www.roche.com/dam/jcr:6c0035b5-3447-4b2c-aeae-9649f5197ccb/en/irp200130.pdf
 
Jan 30, 2020
 
 
c2ed3655-eab6-4407-b40b-17c0fce89e56.jpg